TP53 and breast carcinoma: The p53 heterozygous rats also displayed a delay in tumour onset and a wider spectrum of tumour types, including breast cancer which suggested that these mutant rats might prove to be a useful model for the p53-associated Li-Fraumeni syndrome in humans.